TCL Archive ODAC’s Dilemma: Proposed Indication Created By Reliance On PSA Screening and Hormonal Treatment September 23, 2011
TCL Archive Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML December 28, 2007
TCL Archive NCI Outlines Need For $3,873 Billion To Seize Cancer Research Opportunities October 30, 1998
TCL Archive DCT Board Gives Concept Approval to Recompetition Of In Vitro Assay For New Drug Screening Program February 24, 1984
